Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Paul Turnbull

Use of biomarkers in marketing

Mark Assenti talks about utilisation of biomarkers in marketing is a trend that we have seen growing in 2014 and expect to hear even more about into 2015.

Blue Latitude Health

- PMLiVE

AstraZeneca bullish on diabetes franchise fortunes

Other big pharma firms face a difficult 2015, but AZ is confident it won't

- PMLiVE

Keytruda is UK’s first early-access medicine

Merck’s melanoma therapy accepted under the UK’s EAMS

- PMLiVE

Endo tries to ride out Valeant with $15.7bn bid for Salix

Around $1.2bn more than rival bid

UK flag

Type 1 diabetes vaccine possible ‘within a generation’

Follows the injection of a new funding stream for its research

- PMLiVE

Recipharm promotes Thomas Beck to VP quality management

He joined the organisation in 2010

- PMLiVE

NICE set to back Novartis’ Xolair for skin condition CSU

Issues final draft guidance on the treatment's use as an add-on for chronic spontaneous urticaria

- PMLiVE

Adaptimmune appoints Lawrence Alleva to its board

The former PwC partner will also chair its boardaudit committee

- PMLiVE

FDA clears first therapy for rare childhood cancer

United Therapeutics’ Unituxin approved for neuroblastoma

- PMLiVE

NICE gives nod to blood cancer drug Gazyvaro

Roche’s leukaemia drug to be used in combination with chemotherapy

- PMLiVE

Novo’s Tresiba reduces risk of hypoglycaemia

New clinical data on the diabetes drug also shows blood glucose control benefits

- PMLiVE

Hepatitis C drugs drive US drug costs up in 2014

Played a role in a 13% increase in US prescription spending

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links